RHÖN-KLINIKUM Aktiengesellschaft (RKAGY)
USD 6.05
(0.0%)
USD 6.05
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 155.72 Million EUR | -83.83% |
| 2022 | 963.25 Million EUR | 1.3% |
| 2021 | 950.92 Million EUR | 2.66% |
| 2020 | 926.29 Million EUR | 10.41% |
| 2019 | 838.99 Million EUR | 5.52% |
| 2018 | 795.13 Million EUR | -2.25% |
| 2017 | 813.41 Million EUR | 9.9% |
| 2016 | 740.12 Million EUR | 8.03% |
| 2015 | 685.13 Million EUR | -37.25% |
| 2014 | 1.09 Billion EUR | -46.76% |
| 2013 | 2.05 Billion EUR | 5.3% |
| 2012 | 1.94 Billion EUR | 12.1% |
| 2011 | 1.73 Billion EUR | 2.46% |
| 2010 | 1.69 Billion EUR | 9.9% |
| 2009 | 1.54 Billion EUR | 8.78% |
| 2008 | 1.41 Billion EUR | 160.0% |
| 2007 | -2.36 Billion EUR | -3.73% |
| 2006 | -2.27 Billion EUR | -40.72% |
| 2005 | -1.61 Billion EUR | -38.0% |
| 2004 | -1.17 Billion EUR | -295.49% |
| 2003 | 600.22 Million EUR | 9.06% |
| 2002 | 550.35 Million EUR | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | -22.9 Million EUR | 26.33% |
| 2024 Q1 | -31.08 Million EUR | 15.59% |
| 2023 Q4 | -36.82 Million EUR | -116.25% |
| 2023 Q3 | 226.63 Million EUR | -6.77% |
| 2023 Q2 | 243.08 Million EUR | 3.43% |
| 2023 FY | 155.72 Million EUR | -83.83% |
| 2023 Q1 | 235.02 Million EUR | -5.16% |
| 2022 Q2 | 241.85 Million EUR | 1.98% |
| 2022 Q4 | 247.82 Million EUR | 4.82% |
| 2022 Q3 | 236.41 Million EUR | -2.25% |
| 2022 Q1 | 237.16 Million EUR | -7.13% |
| 2022 FY | 963.25 Million EUR | 1.3% |
| 2021 FY | 950.92 Million EUR | 2.66% |
| 2021 Q4 | 255.38 Million EUR | 10.72% |
| 2021 Q1 | 231.53 Million EUR | -1.3% |
| 2021 Q3 | 230.66 Million EUR | -1.13% |
| 2021 Q2 | 233.3 Million EUR | 0.76% |
| 2020 Q2 | 232.92 Million EUR | 1.4% |
| 2020 Q4 | 234.57 Million EUR | 2.35% |
| 2020 FY | 926.29 Million EUR | 10.41% |
| 2020 Q1 | 229.71 Million EUR | 7.18% |
| 2020 Q3 | 229.19 Million EUR | -1.6% |
| 2019 Q2 | 204.49 Million EUR | -5.73% |
| 2019 Q4 | 214.33 Million EUR | 5.45% |
| 2019 FY | 838.99 Million EUR | 5.52% |
| 2019 Q1 | 216.92 Million EUR | 6.81% |
| 2019 Q3 | 203.26 Million EUR | -0.6% |
| 2018 Q2 | 209.17 Million EUR | 1.65% |
| 2018 Q3 | 176.97 Million EUR | -15.39% |
| 2018 FY | 795.13 Million EUR | -2.25% |
| 2018 Q1 | 205.77 Million EUR | -1.29% |
| 2018 Q4 | 203.08 Million EUR | 14.75% |
| 2017 FY | 813.41 Million EUR | 9.9% |
| 2017 Q2 | 202.54 Million EUR | 0.17% |
| 2017 Q3 | 204.83 Million EUR | 1.13% |
| 2017 Q1 | 202.2 Million EUR | 2.16% |
| 2017 Q4 | 208.46 Million EUR | 1.77% |
| 2016 Q2 | 193.48 Million EUR | 24.32% |
| 2016 FY | 740.12 Million EUR | 8.03% |
| 2016 Q1 | 155.64 Million EUR | -7.49% |
| 2016 Q4 | 197.93 Million EUR | 0.37% |
| 2016 Q3 | 197.2 Million EUR | 1.92% |
| 2015 Q3 | 177.28 Million EUR | -2.64% |
| 2015 Q4 | 168.24 Million EUR | -5.1% |
| 2015 Q1 | 159.65 Million EUR | -19.69% |
| 2015 Q2 | 182.09 Million EUR | 14.05% |
| 2015 FY | 685.13 Million EUR | -37.25% |
| 2014 FY | 1.09 Billion EUR | -46.76% |
| 2014 Q4 | 198.79 Million EUR | 5.26% |
| 2014 Q3 | 188.86 Million EUR | -36.13% |
| 2014 Q2 | 295.68 Million EUR | -28.03% |
| 2014 Q1 | 410.81 Million EUR | -20.02% |
| 2013 Q2 | 515.74 Million EUR | 0.5% |
| 2013 Q3 | 515.25 Million EUR | -0.09% |
| 2013 FY | 2.05 Billion EUR | 5.3% |
| 2013 Q4 | 513.68 Million EUR | -0.31% |
| 2013 Q1 | 513.19 Million EUR | 3.5% |
| 2012 Q1 | 455.72 Million EUR | 4.7% |
| 2012 Q2 | 493.28 Million EUR | 8.24% |
| 2012 Q3 | 502.66 Million EUR | 1.9% |
| 2012 Q4 | 495.85 Million EUR | -1.35% |
| 2012 FY | 1.94 Billion EUR | 12.1% |
| 2011 Q2 | 433.81 Million EUR | 1.12% |
| 2011 Q4 | 435.25 Million EUR | -0.92% |
| 2011 FY | 1.73 Billion EUR | 2.46% |
| 2011 Q1 | 428.98 Million EUR | 0.8% |
| 2011 Q3 | 439.28 Million EUR | 1.26% |
| 2010 Q1 | 416.29 Million EUR | 6.05% |
| 2010 Q3 | 427.61 Million EUR | 0.35% |
| 2010 Q4 | 425.59 Million EUR | -0.47% |
| 2010 Q2 | 426.12 Million EUR | 2.36% |
| 2010 FY | 1.69 Billion EUR | 9.9% |
| 2009 Q3 | 390.4 Million EUR | 0.84% |
| 2009 FY | 1.54 Billion EUR | 8.78% |
| 2009 Q4 | 392.55 Million EUR | 0.55% |
| 2009 Q2 | 387.14 Million EUR | 3.85% |
| 2009 Q1 | 372.78 Million EUR | 0.0% |
| 2008 FY | 1.41 Billion EUR | 160.0% |
| 2007 FY | -2.36 Billion EUR | -3.73% |
| 2006 FY | -2.27 Billion EUR | -40.72% |
| 2005 FY | -1.61 Billion EUR | -38.0% |
| 2004 FY | -1.17 Billion EUR | -295.49% |
| 2003 FY | 600.22 Million EUR | 9.06% |
| 2002 FY | 550.35 Million EUR | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| The Amacore Group, Inc. | 64.06 Million USD | -143.062% |
| Arem Pacific Corporation | 367.08 Thousand USD | -42322.905% |
| Assisted 4 Living, Inc. | 833.9 Thousand USD | -18574.309% |
| BioCorRx Inc. | 3.84 Million USD | -3954.34% |
| Bionik Laboratories Corp. | 5.81 Million USD | -2578.044% |
| Banyan Corp. | 6.59 Million USD | -2260.353% |
| Clearday, Inc. | 5 Million USD | -3012.827% |
| Dental Patient Care America, Inc. | 3.27 Million USD | -4653.744% |
| Quantum Medical Transport, Inc. | 874.76 USD | -17802040.016% |
| Empower Clinics Inc. | 6.92 Million USD | -2149.616% |
| First Choice Healthcare Solutions, Inc. | 2.44 Million USD | -6281.128% |
| Selectis Health, Inc. | 14.36 Million USD | -983.873% |
| Ethema Health Corporation | 5.27 Million USD | -2853.774% |
| HealthLynked Corp. | 9.73 Million USD | -1500.211% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | 9.43 Million USD | -1549.818% |
| JRSIS Health Care Corporation | 671.64 Thousand USD | -23085.622% |
| Comjoyful International Company | - USD | -Infinity% |
| Medical Facilities Corporation | 75.35 Million USD | -106.648% |
| MedSmart Group Inc. | 65.47 Thousand USD | -237754.928% |
| North America Frac Sand, Inc. | 775.75 Thousand USD | -19974.121% |
| Nova Leap Health Corp. | 9.3 Million USD | -1572.993% |
| Nexteligent Holdings, Inc. | 553.38 Thousand USD | -28040.422% |
| PAO Group, Inc. | 45.42 Thousand USD | -342757.772% |
| Primemd Inc. | 6.25 Million USD | -2388.479% |
| Raffles Medical Group Ltd | 151.69 Million USD | -2.66% |
| Ryman Healthcare Limited | 9.61 Million USD | -1519.946% |
| Stem Cell Authority, Ltd. | 4233.00 USD | -3678756.603% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | 1.38 Million USD | -11178.175% |
| Mycotopia Therapies, Inc. | 616.72 Thousand USD | -25150.517% |
| U.S. NeuroSurgical Holdings, Inc. | 765 Thousand USD | -20256.34% |
| Veltex Corporation | 1.77 Million USD | -8662.874% |
| World Financial Holding Group | 28.42 Thousand USD | -547729.452% |
| Xcelerate Inc. | 2.9 Million USD | -5257.331% |